Skip to main content

Table 3 Multivariate analysis of prognostic factors for progression-free survival

From: The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

 

Hazard ratio

95% CI

Standard Error

z

p value

Arterial hypertension

Yes

0.2025

0.1097 - 0.3739

0.0633

-5.11

0.000

Primary tumor

mutation Wild type

0.3292

0.1447 - 0.7491

0.1381

-2.65

0.008

PDGFRA mutation

1.8753

0.9096 - 3.8661

0.0692

1.70

0.049